Manufacturer or GPO Program year 2020 Source: CMS Open Payments

Pfizer Pharmaceuticals LLC

PR, United States

CMS manufacturer 100000000294

Open in the dashboard

General payments

$201,484

1,643 payments

Research payments

$0

0 payments

Ownership & investment interest

$0

None reported

Through program year 2020, Pfizer Pharmaceuticals LLC reported paying $201,484 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $38,607 33
2019 General $162,877 1,610

Breakdown

Top recipients General payments · program year 2020
  1. Alejandro Lopez Mas Interventional Cardiology · Ponce, PR $11,698 6 payments
  2. Luis Garcia Barreto Pulmonary Disease · Coamo, PR $10,500 6 payments
  3. Sonia Vicenty Cardiovascular Disease · San Juan, PR $5,050 2 payments
  4. Luis Gely Cardiovascular Disease · Caguas, PR $2,525 1 payment
  5. Francisco Colon Fontanez Pediatric Dermatology · San Juan, PR $2,525 1 payment
  6. Hector Lozano Gastroenterology · San Juan, PR $2,100 1 payment
  7. Oscar Soto Raices Rheumatology · San Juan, PR $1,625 1 payment
  8. Helder Hernandez Rivera Clinical Cardiac Electrophysiology · Ponce, PR $1,250 1 payment
  9. Angel Davila General Practice · Santurce, PR $97 1 payment
  10. Carlos Carranza General Practice · Bushnell, FL $97 1 payment
Products the payments named General payments · program year 2020
  1. Eliquis Cardiovascular;Metabolic Disease $16,735 43% · 16 recipients
  2. Prevnar 13 Vaccines $10,500 27% · 1 recipient
  3. Vyndaqel Cardiovascular $5,050 13% · 1 recipient
  4. Xeljanz Gastrointestinal;Inflammation;Ophthalmology;Transplant $3,725 10% · 2 recipients
  5. Eucrisa Dermatology $2,525 7% · 1 recipient

Each share is of this company’s general payments naming a product in 2020. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2020
  1. Interventional Cardiology Internal Medicine $11,892 31% · 3 practitioners
  2. Pulmonary Disease Internal Medicine $10,500 27% · 1 practitioner
  3. Cardiovascular Disease Internal Medicine $7,575 20% · 2 practitioners
  4. Pediatric Dermatology Dermatology $2,525 7% · 1 practitioner
  5. Gastroenterology Internal Medicine $2,100 5% · 1 practitioner

The top 5 of 11 specialties; each share is of this company’s general payments to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Puerto Rico $38,607 100% · 22 recipients

Each share is of this company’s general payments in 2020 where a state was reported.

What the payments were for General payments · program years 2019–2020
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $133,725 65 payments
  2. Food and Beverage $54,457 1,541 payments
  3. Travel and Lodging $7,802 34 payments
  4. Space rental or facility fees (teaching hospital only) $5,500 3 payments
Companies with a similar name General payments · program years 2019–2020
  1. Pfizer Inc. NY, United States $513,229,393
  2. Pfizer International LLC NY, United States $1,402,022
  3. Pfizer Chile S.A. Chile $78,355
  4. Pfizer Limited Great Britain (UK) $62,745
  5. Pfizer S.A.S. Colombia $19,741
  6. Pfizer S.A. Peru $18,543
  7. Pfizer Canada Inc Canada $2,036
  8. Pfizer Pharma GMBH Germany $2,030
  9. Pfizer Zona Franca, S.A. Costa Rica $1,395
  10. Pfizer Corporation Hong Kong Limited Hong Kong $653

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent. The largest 10 of 13.

1,643 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record